Structural Formula (Egr00 0001 01)
Egrifta Sv Kit
Product Images NDC 62064-241
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Egrifta Sv (NDC 62064-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Theratechnologies Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Egr00 0001 02)
Figure 2 (Egr00 0001 03)
Figure A (Egr00 0001 04)
This appears to be a product packaging for an injection kit. It includes a injection box with bottle cap, rubber stopper, needle cap, needle shield, needle cap, plunger, sterile water, 1mL syringes, 17 20-gauge needles, and 30-gauge needle. The medication box seems to contain a medication called EGRIFTA SV™ in a 2mg/vial strength.*
Figure B (Egr00 0001 05)
Figure C (Egr00 0001 06)
Figure D (Egr00 0001 07)
Figure E (Egr00 0001 08)
Figure F (Egr00 0001 09)
Figure G (Egr00 0001 10)
Figure I (Egr00 0001 12)
Figure J (Egr00 0001 13)
Figure K (Egr00 0001 14)
Figure L (Egr00 0001 15)
Figure M (Egr00 0001 16)
Figure N (Egr00 0001 17)
Figure O (Egr00 0001 18)
Figure P (Egr00 0001 19)
Figure Q (Egr00 0001 20)
Figure R (Egr00 0001 21)
Figure S (Egr00 0001 22)
Figure T (Egr00 0001 23)
Figure U (Egr00 0001 24)
Figure V (Egr00 0001 25)
Principal Display Panel (Medication Box)
Principal Display Panel (Injection Box)
This is a description of an INJECTION BOX for EGRIFTA SV [tesamorolin for injection] 2 mg/vial. The box contains needle, syringes, sterile water for injection, and materials needed for injecting EGRIFTA SV. However, the INJECTION BOX does NOT contain the medication itself. An important note mentions that you should not remove the contents until you have the EGRIFTA SV 2 mg/vial medication BOX.*
Principal Display Panel (2 mg Vial Label)
This is a medication called EGRIFTASV containing tesamorelin acetate that is injected subcutaneously to treat a specific condition. Each vial contains 2 mg of the medication and is for single-use. The instructions for use should be followed carefully, and any unused medication should be discarded. The medication is distributed by Theratechnologies Inc. Lot and expiration information is provided for tracking and reference purposes.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
